Regeneron Pharmaceuticals Inc. (REGN) rose steadily until mid-morning Tuesday, but settled into a range for the remainder of the session. The stock closed higher by 13.57 at $413.22.
Regeneron Pharmaceuticals climbed past the upper end of nearly a 1-month trading range Tuesday and set a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News